UNSPSC 51111728: Cabazitaxel

This classification denotes a taxane compound and taxane-site binding agent with the molecular formula C45H57NO14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 51F690397J. European Medicines Agency schedules cabazitaxel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31282. The term CABAZITAXEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, no. 3, 2008, list 60). Most nations schedule cabazitaxel under HS 29329990 and SITC 51569.

As of Q4 2014, CABAZITAXEL remains the US FDA Preferred Term for this commodity. Cabazitaxel bears US NLM identifiers UMLS ID C2830183 and NCI Concept Code C66937. SMILES: CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC.

UNSPSC 51111728 Cabazitaxel is a Commodity code nominally describing a specific chemotherapy agent, but recent state and local procurement activity under this code does not reflect cabazitaxel purchases; instead, the opportunities posted show emergency response supplies, multi-source generic pharmaceuticals, and pharmacy benefit program initiatives. State and local governments posting under this code are acquiring medical and first aid supplies for emergency responders, establishing cooperative purchasing frameworks for generic pharmaceuticals and OTC products across multiple jurisdictions, and exploring direct-to-manufacturer prescription fulfillment models through health and human services agencies. The issuing bodies include municipal fire departments, state health and human services commissions, and regional cooperative purchasing alliances. The mismatch between the code's nominal scope and actual procurement suggests either tagging inconsistency or that this code is being applied broadly to pharmaceutical and medical supply acquisitions beyond its narrow product definition.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. The City of Tampa's Purchasing Department issued IFB 26P00145 for medical and first aid supplies to support the Tampa Fire Department Rescue Division, with 169 line items including respiratory equipment, cardiac monitoring electrodes, and medical consumables, due March 13, 2026, with an estimated contract value of $700,000 and a 5% bid discount set-aside for certified Small Local Business Enterprises. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. The Minnesota Department of Administration's Office of State Procurement, on behalf of the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities including Oregon, with proposals due March 26, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 posted April 3, 2026 to gather vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements.